Venezuela Medical Device Family Grouping: Strategy, Criteria and Split Risk

1. Key takeaways

Venezuela permits filing by product family, where a single registration covers multiple models, sizes and variants sharing the same intended use and the same risk class. Grouping done well reduces both the number of registrations and the fees attached to them. Grouping done badly results in a request to split the file — and each file created by a split is timed independently.

The conclusion is that the benefit of grouping is certain while the risk is asymmetric: success saves time and money, failure costs waiting time that has already been spent. A grouping decision should therefore be conservative. Where a model sits on the boundary, it is cheaper to split it out deliberately at the start than to defend the grouping during review, when the only remaining options are to wait for a decision or to accept a split that resets the clock.

This asymmetry also sets the direction of the analysis. The question is not whether a grouping is arguable, but whether it is defensible without discussion. Arguable groupings generate correspondence, and correspondence in this system is measured in months.

2. Legal basis

Basis of the figures: filing by family and the independent timing of files after a split are practical estimates widely cited across the industry. This verification did not locate a Venezuelan official instrument that could be cited directly in support of them.

3. Expert insights

Insight 1: the first constraint on grouping comes from the tariff code, not from product technology. Because regulatory requirements attach to the tariff code (see Article 07), a family that spans codes cannot be grouped in logic: one registration cannot correspond simultaneously to two different legal regime entries. The first step in any grouping exercise is therefore to confirm that all candidate models fall under the same 10-digit tariff code, before any technical analysis is attempted. Skipping this step produces groupings that are technically coherent and administratively impossible.

The check itself is mechanical and should be documented. Obtain the proposed classification for each candidate model, confirm that the 10-digit codes are identical rather than merely adjacent, and record the reasoning behind the classification for each code. Where two models differ only in a component that changes the classification, the grouping cannot proceed regardless of how similar the devices are technically, and the earlier that is discovered the cheaper the redesign of the filing.

Insight 2: four criteria govern the decision. The intended use must be the same; the risk class must be the same; the technical principle and core structure must be the same; and the manufacturer and manufacturing site must be the same. Grouping is advisable only when all four are satisfied, and any single failure calls for a split. The manufacturing site criterion is the one most often overlooked — the same model produced by the same manufacturer at two different plants is normally not the same registered entry, even where every technical document is identical.

Insight 3: implantable devices and reusable surgical instruments usually form their own families. This follows from the traceability requirements attached to both categories (see Article 18). Grouping an implant with routine consumables will almost invariably trigger a request to split, and the request will arrive late enough that the split cannot be absorbed into the original schedule.

Insight 4: the cost of a split is non-linear. Because each file is timed independently after the split, the overall cycle becomes the time taken by the slowest file plus the time consumed by the split itself, not simply the time of one file. If the original file has already been waiting 12 months, a split means that all or part of those 12 months is written off, and the new files start again from the beginning of the queue.

There is a further practical dimension to the same point. A split is rarely refused outright; it usually arrives as a request for clarification that the applicant must answer within a short window. The answer determines whether the original file continues or whether new files are opened, and by then the technical argument has already been made once and lost. Preparing the four-criteria analysis in writing before submission is therefore not paperwork — it is the only opportunity to make that argument under conditions the applicant controls.

4. Practical recommendations

1. Complete the grouping analysis before submission and do not negotiate it during review. The four criteria can be self-assessed in advance; being challenged after filing is far more expensive than being conservative before it.
2. Treat boundary cases as splits. The additional fee paid for a separate registration is far lower than the waiting time lost to a split decision.
3. State the grouping list explicitly in the technical file: enumerate every covered model, size and variant together with a description of the differences, so that the question of coverage does not arise during review.
4. Where the product line is large, submit one representative family first to validate the acceptance position, then file the remainder in batches once that position is confirmed.

5. Verification checklist

• □ All models proposed for grouping fall under the same 10-digit HS code
• □ The four criteria — intended use, risk class, technical principle, manufacturing site — have each been confirmed
• □ The technical file states the grouping list and the differences between models
• □ Implantable devices and reusable surgical instruments are not grouped with routine consumables
• □ Split risk has been assessed and boundary cases have been split out

Regulatory information verified as of October 29, 2026.

GRZAN provides registration support in Venezuela for manufacturers, importers and authorized representatives, including tariff classification review, family grouping assessment and split-risk analysis before filing. For scope and document requirements, contact info@grzanglobal.com.